Pharmacovigilance Conference 2016
 

SPEAKER

Amr Abdel Moneim Abdel Rahman Saad
Associate Minister of Health and Head of the Egyptian Pharmaceutical vigilance Center and the Head of the Arabic higher technical committee for medicines

Dr Amr Saad got his Ph.D. in Epidemiology from The University of Manchester in UK in 2009. He participated in more than 200 national and international conferences where he published many scientific researches all of which are abstracted in the PubMed, and more than 50 posters and countless numbers of speeches in national and international events. He is a well-known worldwide figure in the field of Pharmacovigilance and drug safety monitoring. Currently he is the Associate Minister of Health and Head of the Egyptian Pharmaceutical vigilance Center (EPVC) at the Central Administration for Pharmaceutical Affairs (CAPA).
  • Very recently, he was appointed as the Associate Minister of Health for the pharmaceutical sector. His delegated responsibilities include the reform of the whole sector with increasing capacity and establishing the Egyptian Drug Authority.
  •  Before that, he worked very hard to unify guidelines and performance across the Arab world in the field of Pharmacovigilance. This resulted in the issue of a common decree from the Arab ministers of health [(number 7) in their 37th regular meeting in March 2012] to unify PV guidelines in all Arab World. Thus, "‘The Higher Technical Committee for Medicines" was established with representatives from all Arab countries, to create these common Arab guidelines in pharmacovigilance, and in bioequivalence. This committee elected Dr Amr Saad to lead the committee across all its rounds. The committee finished the final drafts of the two common guidelines which were submitted to the 41st regular ministers meeting, and which has been approved by them.
  • He is also a Lecturer of clinical pharmacy at Future University of Egypt (FUE), Misr International University (MIU), Cairo University & Ain Shams University where he is involved in the construction of the course content, scheduling the content, lecturing, and student evaluations (written and oral).
  • He is also a founding member in the Egyptian Clinical Pharmacy fellowship. His responsibilities included the constructing the course content, facilitating the infrastructure, scheduling the content, lecturing, and co-ordinating with other international bodies for the recognition of the fellowship (university college cork (UCC) in Ireland).
  • He is also a member in some Scientific and Technical Committees within the Egyptian Drug authority like: Pharmacovigilance, Non-Referenced Products, Essential Medicines List, Life Saving medicines, Non-Prescription Medicines, Pharmaco-economics, SSFFC.
  • Being the Head of the Egyptian Pharmaceutical vigilance Center (EPVC), His responsibilities included the construction of a national center to monitor adverse drug reactions (ADRs) from scratch. This included the recruitment of personnel; training and educating them; setting the work plan; defining guidelines and SOPs; structuring the time plan; establishing the national yellow card system; constructing the website; developing the national database for ADRs; conducting awareness campaign in universities, hospitals and for health care professionals (HCPs); and registering and reporting to the WHO-Uppsala Monitoring Center (WHO-UMC). 
 
Dr. Hanan Abd El-Monem
Clinical Operation Director
American Expert Resources Outreach
  • Hanan Abdel-Monem is a MD with extensive research experience in various therapeutic areas. Dr. Abdel-Monem is an American citizen who has spent over 20 years in both Canada and the USA.
  • She worked as a co-investigator and trained as a Post-Doctoral Fellow at Baylor College of Medicine, Houston, TX USA.
  • Dr. Abdel-Monem has a wide range of experience in both in academic and clinical research. She has several publications highly prestigious American journals.
  • She obtained a Master’s degree in Renal Pathology from The University of Alberta, Canada. She was awarded a Hematopathology Post-Doctoral Fellowship by the National Institute of Health. She also had a Post-Doctoral fellowship in field of Pulmonary Medicine at Baylor College of Medicine, Houston, TX, US
 
Dr. Moin Don
CEO & Founder - PVCON
Pharmacovigilance Auditing Consulting Services


Moin Don CEO & Founder of PVCON Pharmacovigilance Auditing Consulting Services

Moin has over 33 years experience in the pharmaceutical industry. Pharmacist by education, Moin is one of the most well known ‘Pharmacovigilance Professionals’ in India. He has rich hands on experience of practically every facet of Industrial Pharmacovigilance, while serving reputed international pharma cos like Sanofi Aventis & his last assignment being, with Johnson & Johnson as Regional PV QA Director for Asia Pacific. Moin has undergone extensive training in U.S, Germany, France & Singapore and is a certified ‘Lead Auditor’. He is closely associated with Govt. of India’s National Pharmacovigilance Program as ‘Advisor’ and ‘Trainer’ for DCGI & CDSCO staff . In addition Moin is also a member of the Central Advisory Committee of DIA India. He is a visiting faculty & international speaker & Course Director of PG Diploma in Pharmacovigilance conducted by Academy for Clinical Excellence. His many articles have been published in international journals of repute. As a distinguished PV consultant & auditor, Moin has conducted audits in India & rest of Asia Pac region besides helping pharma companies in establishing PV systems.